Community partner perspectives on the implementation of a novel safer supply program in Canada: a qualitative study of the MySafe Project
Mansoor M, Foreman-Mackey A, Ivsins A, Bardwell G., Harm Reduct J. 2023
Node
BC
Publications
Priority setting for Canadian Take-Home Naloxone best practice guideline development: an adapted online Delphi method
Ferguson M, Medley A, Rittenbach K, Brothers TD, Strike C, Ng J, Leece P, Elton-Marshall T, Ali F, Lorenzetti DL, Buxton JA.
HIV and Incarceration: Implications for HIV-Positive People Who Use Illicit Drugs During a Seek, Test, Treat, and Retain Initiative in Canada
Blumenkrans E, Hamilton J, Mohd Salleh NA, Kaida A, Small W, Barrios R, Milloy MJ., J Correct Health Care. 2022
Opioid agonist treatment improves progression through the HIV cascade of care among people living with HIV who use unregulated opioids
Juwono S, Milloy MJ, Choi J, Fairbairn N, Nolan S, Socías ME., AIDS. 2022
Suboptimal nonmedical qualities of primary care linked with care avoidance among people who use drugs in a Canadian setting amid an integrated health care reform
Moallef S, Dale L, Homayra F, Zonneveld C, Milloy MJ, Nosyk B, Hayashi K; Vancouver Area Network of Drug Users., J Subst Abuse Treat. 2022
“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada
Glegg S, McCrae K, Kolla G, Touesnard N, Turnbull J, Brothers TD, Brar R, Sutherland C, Le Foll B, Sereda A, Goyer MÈ, Rai N, Bernstein S, Fairbairn N., Canada. Int J Drug Policy. 2022
Cohort Profile: The Assessing Economic Transitions (ASSET) Study-A Community-Based Mixed-Methods Study of Economic Engagement among Inner-City Residents
Richardson L, Minh A, McCormack D, Laing A, Barbic S, Hayashi K, Milloy MJ, Huyser KR, Leahy K, Li J; ASSET Study Team., Int J Environ Res Public Health. 2022
Supporting Self-isolation for COVID-19 With “Risk Mitigation” Prescribing and Housing Supports for People Who Use Drugs: A Case Report
Hong RH, Brar R, Fairbairn N., J Addict Med. 2022
The practice and embodiment of “goofballs”: A qualitative study exploring the co-injection of methamphetamines and opioids
Ivsins A, Fleming T, Barker A, Mansoor M, Thakarar K, Sue K, McNeil R., Int J Drug Policy. 2022
Navigating Opioid Agonist Therapy among Young People who use Illicit Opioids in Vancouver, Canada
Pilarinos A, Kwa Y, Joe R, Thulien M, Buxton JA, DeBeck K, Fast D., Int J Drug Policy. 2022
Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada
Ivsins A, MacKinnon L, Bowles JM, Slaunwhite A, Bardwell G., J Urban Health. 2022
Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial
Socias ME, Wood E, Le Foll B, Lim R, Choi JC, Mok WY, Bruneau J, Rehm J, Wild TC, Bozinoff N, Hassan A, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse.,
Crack cocaine use frequency is associated with HIV disease severity independent of antiretroviral therapy exposure: a prospective cohort study
Macmadu A, Reddon H, Marshall BDL, Fairbairn N, Nolan S, Socías ME, Milloy MJ., AIDS Behav. 2022
Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial
Jutras-Aswad D, Le Foll B, Ahamad K, Lim R, Bruneau J, Fischer B, Rehm J, Wild TC, Wood E, Brissette S, Gagnon L, Fikowski J, Ledjiar O, Masse B, Socias ME; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse., Am J Psychiatry. 2022
Challenges and opportunities for further research involving the cannabis-to-opioid use transition
Bahji A, Milloy MJ, Bach P, Sociás ME., Addiction. 2022
Harm reduction in the hospital: An overdose prevention site (OPS) at a Canadian hospital
Nolan S, Kelian S, Kerr T, Young S, Malmgren I, Ghafari C, Harrison S, Wood E, Lysyshyn M, Holliday E., Alcohol Depend. 2022
Research Participation in Substance Use Disorder Trials: Design and Methods of a Multi-Site Nested Qualitative Study
Foreman-Mackey A, Pauly B, Ivsins A, Urbanoski K, Mansoor M, Bardwell G, Subst Abuse Treat Prev Policy, 2022.
Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada
Foreman-Mackey A, Pauly B, Ivsins A, Urbanoski K, Mansoor M, Bardwell G., Subst Abuse Treat Prev Policy. 2022
The North American opioid crisis: how effective are supervised consumption sites?
Kennedy MC, Karamouzian M, Marshall BDL., Lancet. 2022
The relationship between sexual and gender stigma and suicide attempt and ideation among LGBTQI + populations in Thailand: findings from a national survey
Moallef S, Salway T, Phanuphak N, Kivioja K, Pongruengphant S, Hayashi K., Psychiatry Psychiatr Epidemiol. 2022
Shifts in substance use patterns among a cohort of people who use opioids after delisting of OxyContin in BC, Canada: An interrupted time series study
Karamouzian M, Buxton JA, Hategeka C, Nosova E, Hayashi K, Milloy MJ, Kerr T., Int J Drug Policy. 2022
Primary care embedded within permanent supportive housing for people who use substances: A qualitative study examining healthcare access in Vancouver, Canada
MacKinnon L, Kerman N, Socías ME, Brar R, Bardwell G., Health Soc Care Community. 2022
Predictors of crystal methamphetamine use initiation or re-initiation among people receiving opioid agonist therapy: A prospective cohort study
Cui Z, Hayashi K, Bach P, Dong H, Milloy MJ, Kerr T., Drug Alcohol Depend. 2022
Injecting drugs alone during an overdose crisis in Vancouver, Canada
Norton A, Hayashi K, Johnson C, Choi J, Milloy MJ, Kerr T., Harm Reduct J. 2022
Difficulty accessing supervised consumption services during the COVID-19 pandemic among people who use drugs in Vancouver, Canada
Cassie R, Hayashi K, DeBeck K, Milloy MJ, Cui Z, Strike C, West J, Kennedy MC., Harm Reduct J. 2022
Development and pilot evaluation of an educational session to support sparing opioid prescriptions to opioid naïve patients in a Canadian primary care setting
Narayan S, Rizzardo S, Hamilton MA, Cooper I, Maclure M, McCracken RK, Klimas J., Fam Pract. 2022
Day-to-day impact of COVID-19 and other factors associated with risk of nonfatal overdose among people who use unregulated drugs in five cities in the United States and Canada
Moallef S, Genberg BL, Hayashi K, Mehta SH, Kirk GD, Choi J, DeBeck K, Kipke M, Moore RD, Baum MK, Shoptaw S, Gorbach PM, Mustanski B, Javanbakht M, Siminski S, Milloy MJ., Drug Alcohol Depend. 2022
Prevalence and correlates of stocking up on drugs during the COVID-19 pandemic: Data from the C3PNO Consortium
King L, Hayashi K, Genberg B, Choi J, DeBeck K, Kirk G, Mehta SH, Kipke M, Moore RD, Baum MK, Shoptaw S, Gorbach PM, Mustanski B, Javanbakht M, Siminski S, Milloy MJ., Drug Alcohol Depend. 2022
Opioid agonist therapy engagement and crystal methamphetamine use: The impact of unregulated opioid use in Vancouver, Canada
Cui Z, Bach P, Ti L, Hayashi K, Morgan J, Milloy MJ, Kerr T., Int J Drug Policy. 2022
Use of COVID-19 testing in the first year of the COVID-19 pandemic among cohorts of people at the intersection of drug use and HIV
Gorbach PM, Rosen AD, Moore R, Shoptaw S, Mustanski B, Mehta SH, Kirk GD, Baum MK, Milloy MJ, Hayashi K, DeBeck K, Kipke M, Lai S, Siminski S, Javanbakht M., Drug Alcohol Depend. 2022
Factors associated with self-reported avoidance of harm reduction services during the COVID-19 pandemic by people who use drugs in five cities in the United States and Canada
Feder KA, Choi J, Schluth CG, Hayashi K, DeBeck K, Milloy MJ, Kirk GD, Mehta SH, Kipke M, Moore RD, Baum MK, Shoptaw S, Gorbach PM, Mustanski B, Javanbakht M, Siminski S, Genberg BL., Drug Alcohol Depend. 2022
I’m just trying to stay: Experiences of temporal uncertainty in modular and supportive housing among young people who use drugs in Vancouver
Manson D, Kerr T, Fast D., Int J Drug Policy. 2022
Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study
Kennedy MC, Crabtree A, Nolan S, Mok WY, Cui Z, Chong M, Slaunwhite A, Ti L., PLoS Med. 2022
Cases: Multiorgan failure in a 38-year-old man with recent consumption of kratom, an atypical opioid
Bahji A, Socías ME, Bach P, Psychiatry Res Case Rep, 2022.
Beyond co-production: The construction of drug checking knowledge in a Canadian supervised injection facility
Betsos A, Valleriani J, Boyd J, McNeil R., Soc Sci Med. 2022
The “goldfish bowl”: a qualitative study of the effects of heightened surveillance on people who use drugs in a rural and coastal Canadian setting
Bardwell G, Mansoor M, Van Zwietering A, Cleveland E, Snell D, Kerr T., Harm Reduct J. 2022
Factors Associated with Self-Reported Changes in Alcohol Use among Young Adults during the COVID-19 Pandemic: A Comparative Analysis between Canada and France
Coulaud PJ, Airagnes G, McGrath K, Bolduc N, Bertrand K, Jauffret-Roustide M, Knight R., Int J Environ Res Public Health. 2022
Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy
Moallef S, DeBeck K, Fairbairn N, Cui Z, Brar R, Wilson D, Johnson C, Milloy MJ, Hayashi K., Addict Sci Clin Pract. 2022
Factors Influencing the Acceptability of Nominal, Non-nominal, and Anonymous HIV Testing Options Among Young Men Living in Vancouver, Canada: A Qualitative Study
Lowik AJ, Prangnell A, Carson A, Wong J, Knight R., Assoc Nurses AIDS Care. 2023
Transitions in care between hospital and community settings for individuals with a substance use disorder: A systematic review
James H, Morgan J, Ti L, Nolan S., Drug Alcohol Depend. 2023
Association of sex work and social-structural factors with non-fatal overdose among women who use drugs in Vancouver, Canada
Harris MT, Goldenberg S, Cui Z, Fairbairn N, Milloy MS, Hayashi K, Samet JH, Walley AY, Nolan S., Int J Drug Policy. 2023
Young Adults’ Mental Health and Unmet Service Needs in the Context of the COVID-19 Pandemic Across Canada and France
Coulaud PJ, Jesson J, Bolduc N, Ferlatte O, Jenkins E, Bertrand K, Salway T, Jauffret-Roustide M, Knight R., Community Ment Health J. 2023
Autonomy and (In)Capacity to Consent in Adolescent Substance Use Treatment and Care
Goodyear T, Jenkins E, Knight R, Sedgemore KO, White M, Culham T, Fast D., Adolesc Health. 2023
The Cannabis-Dependent Relationship Between Methadone Treatment Dose and Illicit Opioid Use in a Community-Based Cohort of People Who Use Drugs
Lake S, Kerr T, Buxton J, Walsh Z, Cooper ZD, Socías ME, Fairbairn N, Hayashi K, Milloy MJ., Cannabis Cannabinoid Res. 2023
Methadone Maintenance Treatment Discontinuation Among Young People who use Opioids in Vancouver, Canada
Pilarinos A, Kwa Y, Joe R, Dong H, Grant C, Fast D, Buxton JA, DeBeck K., Can J Psychiatry. 2023
Emergency department experiences of people who use drugs who left or were discharged from hospital against medical advice
Mayer S, Langheimer V, Nolan S, Boyd J, Small W, McNeil R., PLoS One. 2023
Pathways connecting socioeconomic marginalization and overdose: A qualitative narrative synthesis
van Draanen J, Jamula R, Karamouzian M, Mitra S, Richardson L., Int J Drug Policy. 2023
Increasing trends and incidence of nonfatal overdose among women sex workers who use drugs in British Columbia: The role of criminalization-related barriers to harm reduction
Argento E, Shannon K, Fairbairn N, Moreheart S, Braschel M, Goldenberg S., Drug Alcohol Depend. 2023
Examining fentanyl and its analogues in the unregulated drug supply of British Columbia, Canada using drug checking technologies
Crepeault H, Socias ME, Tobias S, Lysyshyn M, Custance A, Shapiro A, Ti L. , Drug Alcohol Rev. 2023
A Hospital-based Managed Alcohol Program in a Canadian Setting
Nolan S, Fairgrieve C, Dong H, Garrod E, van Heukelom H, Parappilly BP, McLean M, Tsui JI, Samet JH., J Addict Med. 2023
Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study
Bardwell G, Bowles JM, Mansoor M, Werb D, Kerr T., Subst Abuse Treat Prev Policy. 2023
The impact of the COVID-19 pandemic on access to supervised consumption programs
Gubskaya E, Kennedy MC, Hayashi K, Cui Z, Milloy MJ, Kerr T., Subst Abuse Treat Prev Policy. 2023
The perspectives of street-involved youth who use drugs regarding the acceptability and feasibility of HIV pre-exposure prophylaxis: a qualitative study
Dahlby L, Boyd J, Knight R, Philbin M, Small W, Kerr T, McNeil R., AIDS Care. 2023
Women who use drugs: engagement in practices of harm reduction care
Austin T, Lavalley J, Parusel S, Collins AB, Olding M, Boyd J., Harm Reduct J. 2023
Interest in using buprenorphine-naloxone among a prospective cohort of street-involved young people in Vancouver, Canada
Pilarinos A, Bingham B, Kwa Y, Joe R, Grant C, Fast D, Buxton JA, DeBeck K., J Subst Use Addict Treat. 2023
Assessing options for poppers policy in Canada: A call to action for evidence-based policy reform
Schwartz C, Card K, Elliott R, Hollett K, Jollimore J, Pasic A, Smiley S, Tooley L, Pruden H, Knight R., Int J Drug Policy. 2023
Estimating the prevalence and correlates of pain among people living with HIV who use unregulated drugs in a Canadian setting
Loh J, Buxton J, Kaida A, Voon P, Grant C, Milloy MJ., J Opioid Manag. 2023
Using photovoice to understand experiences of opioid use among sexual and gender minority youth in Vancouver, Canada
Goodyear T, Ferlatte O, Fast D, Salway T, Jenkins E, Robinson S, Knight R., Cult Health Sex. 2023
Perceived Mistreatment in Health Care Settings and its Relationship with HIV Clinical Outcomes in HIV-positive People who Use Drugs in Vancouver, Canada
Jaibat L, Cui Z, Mitra S, Loh J, Reddon H, Fairbairn N, Milloy MJ., AIDS Behav. 2023
“It’s no foundation, there’s no stabilization, you’re just scattered”: A qualitative study of the institutional circuit of recently-evicted people who use drugs
Fleming T, Collins AB, Boyd J, Knight KR, McNeil R., Soc Sci Med. 2023
Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies
Giang K, Charlesworth R, Thulien M, Mulholland A, Barker B, Brar R, Pauly B, Fast D., Int J Drug Policy. 2023
Socioeconomic marginalization and risk of overdose in a community-recruited cohort of people who use drugs: A longitudinal analysis
Mitra S, Choi J, van Draanen J, Kerr T, Gilbert M, Hayashi K, Milloy MJ, Johnson C, Richardson L., Int J Drug Policy. 2023
Re-incarceration and associated social, structural and behavioural factors among people who use drugs in an urban Canadian setting
Brooks O, Hayashi K, Cui Z, Milloy MJ, Kerr T, Fairbairn N., Int J Drug Policy. 2023
Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes
Bardwell G, Ivsins A, Mansoor M, Nolan S, Kerr T., CMAJ. 2023
First-line opioid agonist treatment as prevention against assisting others in initiating injection drug use: A longitudinal cohort study of people who inject drugs in Vancouver, Canada
Bouck Z, Tricco AC, Rosella LC, Banack HR, Fox MP, Platt RW, Milloy MJ, DeBeck K, Hayashi K, Werb D., Drug Alcohol Depend Rep. 2023
Experiences of violence during the COVID-19 pandemic among people who use drugs in a Canadian setting: a gender-based cross-sectional study
Swaich A, Richardson L, Cui Z, DeBeck K, Milloy MJ, Kerr T, Hayashi K., BMC Public Health. 2023
Cost-effectiveness of flexible take-home buprenorphine-naloxone versus methadone for treatment of prescription-type opioid use disorder
Enns B, Krebs E, Whitehurst DGT, Jutras-Aswad D, Le Foll B, Socias ME, Nosyk B; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse., Drug Alcohol Depend. 2023
Opioid agonist therapy switching among individuals with prescription-type opioid use disorder: Secondary analysis of a pragmatic randomized trial
Mocanu V, Bozinoff N, Wood E, Jutras-Aswad D, Le Foll B, Lim R, Cheol Choi J, Yin Mok W, Eugenia Socias M; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse.,
Development of a neural network model to predict the presence of fentanyl in community drug samples
Ti L, Grant CJ, Tobias S, Hore DK, Laing R, Marshall BDL., PLoS One. 2023
Experiencing homelessness and progression through the HIV cascade of care among people who use drugs
Reddon H, Fairbairn N, Grant C, Milloy MJ., AIDS. 2023
Supervised smoking facility access, harm reduction practices, and substance use changes during the COVID-19 pandemic: a community-engaged cross-sectional study
van Draanen J, Hamilton J, Morgan J, Maxwell S, Taylor T, Richardson L, Nolan S., Harm Reduct J. 2023
Differentiating the role of alcohol in young men’s use of substances with sex: A qualitative study
Goodyear T, Oliffe JL, Parent N, Mniszak C, Jenkins E, Knight R., Harm Reduct J. 2023
Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: An interrupted time series analysis
Eugenia Socias M, Choi JC, Fairbairn N, Johnson C, Wilson D, Debeck K, Brar R, Hayashi K, Int J Drug Policy. 2023
Trends in cocaine and crystal methamphetamine injection over time in a Canadian setting between 2008 and 2018
Bach P, Ti L, Hayashi K, Cui Z, Milloy MJ, Fairbairn N., J Subst Use Addict Treat. 2023
Crystal methamphetamine use and methadone maintenance treatment dissatisfaction: A prospective cohort study in Vancouver, Canada
Cui Z, Hayashi K, Bach P, Milloy MJ, Kerr T., J Subst Use Addict Treat. 2023
Use of Cannabis as a Harm Reduction Strategy Among People Who Use Drugs: A Cohort Study
Mok J, Milloy MJ, Grant C, Lake S, DeBeck K, Hayashi K, Kerr T, Socías ME., Cannabis Cannabinoid Res. 2023
Sensitivity to change of generic preference-based instruments (EQ-5D-3L, EQ-5D-5L, and HUI3) in the context of treatment for people with prescription-type opioid use disorder in Canada
Whitehurst DGT, Mah C, Krebs E, Enns B, Socias ME, Jutras-Aswad D, Le Foll B, Nosyk B; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse., Qual Life Res. 2023
Police seizure of drugs without arrest among people who use drugs in Vancouver, Canada, before provincial ‘decriminalization’ of simple possession: a cohort study
Hayashi K, Singh Kelsall T, Shane C, Cui Z; Vancouver Area Network of Drug Users; Milloy MJ, DeBeck K, Kerr T., Harm Reduct J. 2023
Decriminalization thresholds for drug possession: A multi-criteria policy analysis framework
McAdam E, Small W, Mullins G, Graham B, Greer A, Winder N, DeBeck K., Int J Drug Policy. 2023
RE: Incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada
Elefante J, Nolan S, Bach P, CMAJ, 2023
“We just don’t have the space for it”: Geographies of survival and spatial triage in overdose prevention sites
Olding M, Boyd J, Kerr T, McNeil R., Health Place. 2023
Latent polydrug use patterns and the provision of injection initiation assistance among people who inject drugs in three North American settings
Rammohan I, Jain S, Sun S, Marks C, Milloy MJ, Hayashi K, DeBeck K, González-Zúñiga P, Strathdee S, Werb D., Drug Alcohol Rev. 2023
Housing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study
Chayama KL, Ng C, Fleming T, Small W, Sue KL, McNeil R., Harm Reduct J. 2023
“Anticipate the need”: a narrative analysis of service providers’ experiences working with sexual and gender minority youth in British Columbia, Canada, during the COVID-19 pandemic
McKenzie S, Hesse C, Carson A, Goodyear T, Knight R, Crit Public Health, 2023.
Longitudinal latent polysubstance use patterns among a cohort of people who use opioids in Vancouver, Canada
Karamouzian M, Cui Z, Hayashi K, DeBeck K, Milloy MJ, Buxton JA, Kerr T., Drug Alcohol Rev. 2023
Cannabis use to manage opioid cravings among people who use unregulated opioids during a drug toxicity crisis
Reddon H, Lake S, Socias ME, Hayashi K, DeBeck K, Walsh Z, Milloy MJ., Int J Drug Policy. 2023
Cannabis use to manage stimulant cravings among people who use unregulated drugs
Reddon H, Socias ME, DeBeck K, Hayashi K, Walsh Z, Milloy MJ., Addict Behav. 2024
Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis
Karamouzian M, Rafat B, Kolla G, Urbanoski K, Atkinson K, Bardwell G, Bonn M, Touesnard N, Henderson N, Bowles J, Boyd J, Brunelle C, Eeuwes J, Fikowski J, Gomes T, Guta A, Hyshka E, Ivsins A, Kennedy MC, Laurence G, Martignetti L, Nafeh F, Salters K, Tu D, Strike C, Pauly B, Werb D., Int J Drug Policy. 2023
Document d’orientation sur la distribution et l’utilisation de trousses de naloxone à emporter par les intervenants et intervenantes communautaires en cas de surdose au Canada
Ferguson M, Rittenbach K, Leece P, Adams A, Ali F, Elton-Marshall T, Burmeister C, Brothers TD, Medley A, Choisil P, Strike C, Ng J, Lorenzetti DL, Gallant K, Buxton JA; le groupe d’élaboration des documents d’orientation relative à la naloxone, CMAJ, 2023
Vigilance needed with methamphetamine-associated psychosis
Elefante RJO, Nolan S, Bach PJ., CMAJ. 2023
Commentary on Brothers et al.: The role of safer environment interventions in addressing injecting-related bacterial and fungal infections
Small W, O’Callaghan S., Addiction. 2023
What impact did the COVID-19 pandemic have on the variability of fentanyl concentrations in the Vancouver, Canada illicit drug supply? An interrupted time-series analysis
Tobias S, Grant CJ, Laing R, Lysyshyn M, Buxton JA, Tupper KW, Wood E, Ti L, BMJ Public Health, 2023.
Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packs
Duncan K, Scheuermeyer F, Lane D, Ahamad K, Moe J, Dong K, Nolan S, Buxton J, Miles I, Johnson C, Christenson J, Whyte M, Daoust R, Garrod E, Badke K, Kestler A., CJEM. 2023
Safety and Efficacy of Rapid Methadone Titration for Opioid Use Disorder in an Inpatient Setting: A Retrospective Cohort Study
Klaire S, Fairbairn N, Ryan A, Nolan S, McLean M, Bach P., J Addict Med. 2023
Responding to changes in the unregulated drug supply: the need for a dynamic approach to drug checking technologies
Bhuiyan I, Tobias S, Ti L., Am J Drug Alcohol Abuse. 2023
“I thought it was for guys that did needles”: Medication perceptions and lay expertise among medical research participants
Jaffe K, Richardson L., Subst Use Addict Treat. 2023
Evaluation of audit and feedback to family physicians on prescribing of opioid analgesics to opioid-naïve patients: A pragmatic randomized delay trial
McCracken RK, Narayan S, Maclure M, Cooper I, Cui Z, Cullen W, Dormuth C, Hamilton MA, Nolan S, Singer J, Socías ME, Wong S, Klimas J., Contemp Clin Trials. 2023
Universal Access to Opioid Agonist Therapy in Residential Treatment Settings: The Time Is Now
Muir P, Nolan S, Can J Addict, 2023
Correlates of nonfatal overdose among treatment-seeking individuals with non-heroin opioid use disorder: Findings from a pragmatic, pan-Canadian, randomized control trial
Crepeault H, Ti L, Jutras-Aswad D, Wood E, Le Foll B, Lim R, Bach P, Brar R, Socias ME., J Subst Use Addict Treat. 2023
